Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.
Who will be affected?
Readers: No access to all 28 journals. We recommend accessing our articles via PubMed Central
Authors: No access to the submission form or your user account.
Reviewers: No access to your user account. Please download manuscripts you are reviewing for offline reading before Wednesday, July 01, 2020 at 7:00 PM.
Editors: No access to your user account to assign reviewers or make decisions.
Copyeditors: No access to user account. Please download manuscripts you are copyediting before Wednesday, July 01, 2020 at 7:00 PM.
The Impact of COVID-19 on Cancer-Screening: Challenges and Opportunities
Ramon S Cancino;
Zhaohui Su;
Ruben Mesa;
Gail Tomlinson;
Jing Wang
ABSTRACT
Cancer is a leading cause of deaths in the U.S. and across the globe. Cancer screening is an effective preventive measure that can reduce cancer incidence and mortality. While cancer screening is integral to cancer control and prevention, due to the coronavirus outbreak many screenings have either been cancelled or postponed, leaving a vast number of patients without access to recommended healthcare services. This disruption to cancer screening services may have a significant impact on patients, healthcare practitioners, and health systems. In this article, we aim to offer a comprehensive view of the impact of COVID-19 on cancer screening. Specially, we present challenges COVID-19 exerted on patients, healthcare practitioners, and health systems as well as potential opportunities that could help address these challenges.
Citation
Please cite as:
Cancino RS, Su Z, Mesa R, Tomlinson G, Wang J
The Impact of COVID-19 on Cancer Screening: Challenges and Opportunities